Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Bohlin Garen G received 8,741 Collegium Pharmaceutical, Inc. shares as an award (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Bohlin Garen G (Director) received 8,741 Collegium Pharmaceutical, Inc. shares as an award, leaving 71,000 shares. Filed May 18, 2026 (Form 4).
- Awarded
- 8,741 shares
- Holding after
- 71,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Award | 8,741 | 71,000 | Direct |
Source
Related
- Collegium Pharmaceutical, Inc.
- Bohlin Garen G
- Collegium Pharmaceutical, Inc. shareholders
- Form 4 · Bohlin Garen G · May 13, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026